Advertisement

Topics

Search Results for "Graves Disease And Agent Orange "

14:17 EDT 28th July 2016 | BioPortfolio

Matching Channels

Graves' disease

Congenital Graves' disease

Eye disease

Xofigo (radium-223 dichloride)

New treatment for castration-resistant prostate cancer (CRPC) patients with bone metastases. Xofigo shown in a pivotal phase III trial to significantly improve overall survival. Xofigo® with...

p38 mitogen activated protein kinase MAPK Inhibitors

The next generation of p38 mitogen-activated protein kinase (MAPK) inhibitors has reached clinical proof-of-concept studies in phase II in a broad range of indications. While the previous generation o...

Matching News

Final review of health problems that may be linked to Agent Orange exposure during Vietnam War

The latest and final in a series of congressionally mandated biennial reviews of the evidence of health problems that may be linked to exposure to Agent Orange and other herbicides used during the Vie...

Later onset, longer duration of Graves’ hyperthyroidism, smoking predictors for Graves’ orbitopathy

In patients with Graves’ hyperthyroidism, predictive factors for Graves’ orbitopathy include older age of disease onset, longer disease duration and smoking, according to recent findings in a larg...

Misstated Terminology

In the Review entitled “Management of Graves Disease: A Review” published in the December 15, 2015, issue of JAMA, one of the complications associated with surgery for hyperthyroidism caused by Gr...

Immunosuppressive therapy may reduce relapse risk in Graves’ disease

The addition of immunosuppressive drugs to the standard treatment of Graves’ disease may reduce the risk for relapse, according to study data. Tristan Mirko Struja, MD, of the department of medicine...

Agent Orange Linked to Bladder Cancer, Thyroid Problems, Panel Says

THURSDAY, March 10, 2016 -- There is stronger evidence of a link between the herbicide Agent Orange and bladder cancer and thyroid problems among U.S. military personnel exposed to the chemical during...

Self-reported Agent Orange exposure higher among veterans with thyroid cancer

Self-reported Agent Orange exposure was more prevalent among patients with thyroid cancer compared with the overall national Veterans Affairs patient population, study results show.Angela M. Leung, MD...

Managing Neonates Born to Mothers With Graves' Disease

A new literature-based algorithm provides guidance for physicians on managing neonates born to mothers with Graves' disease (GD). Reuters Health Information

Interprofessional education good for health care, optometry, patients

Just the other day a long-term patient presented with acute onset diplopia. While her demographic profile and clinical findings were consistent with a subtle ischemic sixth nerve palsy, my differentia...

Matching PubMed Articles

Management of hyperthyroidism due to Graves' disease: frequently asked questions and answers (if any).

Graves' disease is the most common cause of hyperthyroidism in iodine-replete areas. Although progress has been made in our understanding of the pathogenesis of the disease, no treatment targeting pat...

The management of Graves' disease in New Zealand 2014.

Treatment options for Graves' disease (GD), namely anti-thyroid drugs (ATD), surgery or radioiodine (RAI), have not changed over the past two decades. There is no 'gold-standard' treatment for GD.

Outcomes in Relapsed Graves' disease Patients Following Radioiodine or Prolonged Low-Dose of Methimazole Treatment.

Low doses of anti-thyroid drugs (ATD) for extended periods may be an alternative for Graves' disease (GD) patients who relapse after a course of ATD.

Presence of Thyroid-Stimulating Hormone Receptor Antibodies in a Patient with Subacute Thyroiditis followed by Hypothyroidism and Later Graves' Disease with Ophthalmopathy: A Case Report.

The development of Graves' disease (GD) after subacute thyroiditis (SAT) is very rare and only a limited number of cases have been reported.

Thyroid surgery for Graves' disease and Graves' ophthalmopathy.

Graves' disease is an autoimmune disease caused by the production of auto-antibodies against the thyroid-stimulating hormone receptor, which stimulates follicular cell production of thyroid hormone. I...

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement